BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21109536)

  • 41. Three-dimensional collagen represses cyclin E1 via β1 integrin in invasive breast cancer cells.
    Wu Y; Guo X; Brandt Y; Hathaway HJ; Hartley RS
    Breast Cancer Res Treat; 2011 Jun; 127(2):397-406. PubMed ID: 20607601
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E- and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice.
    Tong W; Pollard JW
    Mol Cell Biol; 1999 Mar; 19(3):2251-64. PubMed ID: 10022912
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stem cell factor inhibits erythroid differentiation by modulating the activity of G1-cyclin-dependent kinase complexes: a role for p27 in erythroid differentiation coupled G1 arrest.
    Tamir A; Petrocelli T; Stetler K; Chu W; Howard J; Croix BS; Slingerland J; Ben-David Y
    Cell Growth Differ; 2000 May; 11(5):269-77. PubMed ID: 10845428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Study of the cell cycle-dependent assembly of the DNA pre-replication centres in Xenopus egg extracts.
    Adachi Y; Laemmli UK
    EMBO J; 1994 Sep; 13(17):4153-64. PubMed ID: 8076611
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nuclear matrix binding is critical for progesterone receptor movement into nuclear foci.
    Graham JD; Hanson AR; Croft AJ; Fox AH; Clarke CL
    FASEB J; 2009 Feb; 23(2):546-56. PubMed ID: 18931262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclin E1 plays a key role in balancing between totipotency and differentiation in human embryonic cells.
    Krivega MV; Geens M; Heindryckx B; Santos-Ribeiro S; Tournaye H; Van de Velde H
    Mol Hum Reprod; 2015 Dec; 21(12):942-56. PubMed ID: 26416983
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The histone gene activator HINFP is a nonredundant cyclin E/CDK2 effector during early embryonic cell cycles.
    Xie R; Medina R; Zhang Y; Hussain S; Colby J; Ghule P; Sundararajan S; Keeler M; Liu LJ; van der Deen M; Mitra P; Lian JB; Rivera-Perez JA; Jones SN; Stein JL; van Wijnen AJ; Stein GS
    Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12359-64. PubMed ID: 19590016
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct transdifferentiation of spermatogonial stem cells to morphological, phenotypic and functional hepatocyte-like cells via the ERK1/2 and Smad2/3 signaling pathways and the inactivation of cyclin A, cyclin B and cyclin E.
    Zhang Z; Gong Y; Guo Y; Hai Y; Yang H; Yang S; Liu Y; Ma M; Liu L; Li Z; Gao WQ; He Z
    Cell Commun Signal; 2013 Sep; 11():67. PubMed ID: 24047406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Developmental and cell cycle regulation of the Drosophila histone locus body.
    White AE; Leslie ME; Calvi BR; Marzluff WF; Duronio RJ
    Mol Biol Cell; 2007 Jul; 18(7):2491-502. PubMed ID: 17442888
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulation of the Raf/MEK/ERK cascade is necessary and sufficient for activation and Thr-160 phosphorylation of a nuclear-targeted CDK2.
    Lents NH; Keenan SM; Bellone C; Baldassare JJ
    J Biol Chem; 2002 Dec; 277(49):47469-75. PubMed ID: 12359725
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Altered subcellular localization of tumor-specific cyclin E isoforms affects cyclin-dependent kinase 2 complex formation and proteasomal regulation.
    Delk NA; Hunt KK; Keyomarsi K
    Cancer Res; 2009 Apr; 69(7):2817-25. PubMed ID: 19318554
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of cyclin E-cyclin-dependent kinase 2 complex formation and activity is associated with cell cycle arrest and withdrawal in oligodendrocyte progenitor cells.
    Ghiani C; Gallo V
    J Neurosci; 2001 Feb; 21(4):1274-82. PubMed ID: 11160398
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2.
    Cueille N; Nougarede R; Mechali F; Philippe M; Bonne-Andrea C
    J Virol; 1998 Sep; 72(9):7255-62. PubMed ID: 9696820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
    Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
    Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The C-terminal domain of the Xenopus cyclin-dependent kinase inhibitor, p27Xic1, is both necessary and sufficient for phosphorylation-independent proteolysis.
    Chuang LC; Zhu XN; Herrera CR; Tseng HM; Pfleger CM; Block K; Yew PR
    J Biol Chem; 2005 Oct; 280(42):35290-8. PubMed ID: 16118210
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Activation of Cdk2/Cyclin E complexes is dependent on the origin of replication licensing factor Cdc6 in mammalian cells.
    Lunn CL; Chrivia JC; Baldassare JJ
    Cell Cycle; 2010 Nov; 9(22):4533-41. PubMed ID: 21088490
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thr199 phosphorylation targets nucleophosmin to nuclear speckles and represses pre-mRNA processing.
    Tarapore P; Shinmura K; Suzuki H; Tokuyama Y; Kim SH; Mayeda A; Fukasawa K
    FEBS Lett; 2006 Jan; 580(2):399-409. PubMed ID: 16376875
    [TBL] [Abstract][Full Text] [Related]  

  • 58. PKCeta associates with cyclin E/Cdk2 complex in serum-starved MCF-7 and NIH-3T3 cells.
    Shtutman M; Hershko T; Maissel A; Fima E; Livneh E
    Exp Cell Res; 2003 May; 286(1):22-9. PubMed ID: 12729791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Kinase-independent function of E-type cyclins in liver cancer.
    Geng Y; Michowski W; Chick JM; Wang YE; Jecrois ME; Sweeney KE; Liu L; Han RC; Ke N; Zagozdzon A; Sicinska E; Bronson RT; Gygi SP; Sicinski P
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1015-1020. PubMed ID: 29339491
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis.
    Pok S; Barn VA; Wong HJ; Blackburn AC; Board P; Farrell GC; Teoh NC
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1210-9. PubMed ID: 26574916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.